Literature DB >> 11045690

T1 lung cancer on CT: frequency of extrathoracic metastases.

K J Jung1, K S Lee, H Kim, O J Kwon, J Kim, Y M Shim, T S Kim.   

Abstract

PURPOSE: To determine the frequency of extrathoracic metastases in T1 non-small-cell lung cancer.
METHOD: Ninety patients with T1 lung cancer identified on CT were included. Extrathoracic metastases were evaluated at the time of initial diagnosis and during a 1-year follow-up study. The frequency of metastases was compared in terms of cell type (squamous or nonsquamous), size (<2 cm or >2 cm), and the initial CT findings of the tumor.
RESULTS: Extrathoracic metastases were identified in 12 (13%) of 90 patients at the time of diagnosis and in 10 patients at the 1-year follow-up study (total, 22 of 90 [24%] patients). Tumors with ground-glass opacity on CT were associated with a significantly lower prevalence of metastases (p = 0.042). The area of ground-glass opacity was seen in 1 of 13 (85%) patients with bronchioloalveolar carcinoma and in 12 of 53 (23%) patients with adenocarcinoma other than bronchioloalveolar carcinoma (p < 0.001). There was no significant difference in the prevalence of metastases between squamous and nonsquamous cell carcinoma, between tumors smaller than 2 cm (n = 17) and larger than 2 cm in diameter (n = 73) and between tumors with or without mediastinal nodal metastases (p>0.05).
CONCLUSION: Extrathoracic metastases were apparent at the initial examination in 13% of patients and at the 1-year follow-up examination in 11% of patients. The prevalence is significantly lower in tumors with ground-glass opacity.

Entities:  

Mesh:

Year:  2000        PMID: 11045690     DOI: 10.1097/00004728-200009000-00008

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol.

Authors:  Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01       Impact factor: 9.236

2.  Can clinical factors be determinants of bone metastases in non-small cell lung cancer?

Authors:  Ahmet Ursavas; Mehmet Karadag; Esra Uzaslan; Erkan Rodoplu; Ezgi Demirdögen; Basak Burgazlioglu; R Oktay Gozu
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

3.  Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study.

Authors:  Bing Chen; Xiaojun Wang; Xinnian Yu; Wen-Jie Xia; Heng Zhao; Xiao-Fei Li; Lun-Xu Liu; Yang Liu; Jian Hu; Xiang-Ning Fu; Yin Li; Yi-Jun Xu; De-Ruo Liu; Hai-Ying Yang; Lin Xu; Feng Jiang
Journal:  Thorac Cancer       Date:  2019-01-21       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.